Efficacy of urtoxazumab (TMA-15 humanized monoclonal antibody specific for Shiga toxin 2) against post-diarrheal neurological sequelae caused by Escherichia coli O157:H7 infection in the neonatal gnotobiotic piglet model

Rodney A. Moxley, David H. Francis, Mizuho Tamura, David B. Marx, Kristina Santiago-Mateo, Mojun Zhao

Research output: Contribution to journalArticlepeer-review

6 Scopus citations

Fingerprint Dive into the research topics of 'Efficacy of urtoxazumab (TMA-15 humanized monoclonal antibody specific for Shiga toxin 2) against post-diarrheal neurological sequelae caused by Escherichia coli O157:H7 infection in the neonatal gnotobiotic piglet model'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds